Evidence map›Paper›PMID 28662664›Full record

ArticleMolecular cancer2017

Dual role for p16 in the metastasis process of HPV positive head and neck cancers.

Rüveyda Dok, Mary Glorieux, Karolina Holacka, Marieke Bamps, Sandra Nuyts

Open access · goldAbstract readLetter
In one paragraph

Article in Molecular cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Metastatic disease in head & neck oncology.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2020
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rüveyda DokDepartment of Oncology, Laboratory of Experimental Radiotherapy, KU Leuven, University of Leuven, 3000, Leuven, Belgium.
Mary GlorieuxDepartment of Oncology, Laboratory of Experimental Radiotherapy, KU Leuven, University of Leuven, 3000, Leuven, Belgium.
Karolina HolackaDepartment of Oncology, Laboratory of Experimental Radiotherapy, KU Leuven, University of Leuven, 3000, Leuven, Belgium.
Marieke BampsDepartment of Oncology, Laboratory of Experimental Radiotherapy, KU Leuven, University of Leuven, 3000, Leuven, Belgium.
Sandra NuytsDepartment of Oncology, Laboratory of Experimental Radiotherapy, KU Leuven, University of Leuven, 3000, Leuven, Belgium. sandra.nuyts@uzleuven.be.
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies show that human papillomavirus (HPV) positive head and neck cancers (HNSCC) are typically characterized by low tumor and high regional node stages, intrinsically indicating high local metastatic potential. Despite this, the distant metastasis rates of HPV positive and negative HNSCC are similar. To date, majority of the studies focus on molecular characterization of HPV positive disease and on treatment outcome. Here we assessed the biological mechanisms of metastasis by combining in vitro and in vivo head and neck carcinoma xenograft models with patient data. We provide experimental evidence for a dual role of p16, a surrogate marker for HPV infections, in the metastasis process of HNSCC. We found that p16 regulates the invasiveness and metastatic potential of HNSCC cells by impairing angiogenesis. In parallel, we found that p16 is regulating the nodal spread by mediating lymphatic vessel formation through the upregulation of integrins. These findings not only provide understanding of the biology of the different dissemination patterns but also suggest that inhibition of lymphangiogenesis in HPV positive cancers and inhibition of angiogenesis in HPV negative cancers can form a treatment strategy against metastasis.

Indexed as

AgedCarcinoma, Squamous CellCell MovementCyclin-Dependent Kinase Inhibitor p16FemaleHead and Neck NeoplasmsHumansLymphangiogenesisLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessNeovascularization, PathologicPapillomaviridaePapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckCyclin-Dependent Kinase Inhibitor p16Vascular Endothelial Growth Factor AAngiogenesisHead and neck cancerHPVLymphangiogenesisMetastasisP16

Identifiers

PMID28662664
PMCPMC5492443
OpenAlexW2730541855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.